Tech Company Financing Transactions

Spruce Biosciences Funding Round

Spruce Biosciences, operating out of San Francisco, scored $88 million in funding from Abingworth, Omega Funds and Aisling Capital.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1700 Montgomery St. 212
San Francisco, CA 94111
USA

Phone

Undisclosed

Website

www.sprucebiosciences.com

Email Address

[email protected]

Overview

Spruce Biosciences (Nasdaq: SPRB) is a clinical-stage biopharmaceutical based in San Francisco, California. Our mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis (the stress pathway).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Richard King

        

Chief Medical Officer

Kamal Bharucha

        

Chief Medical Officer

Michael Huang

        

Vice President

Chris Barnes

        

VP - Manufacturing

Sangita Ghosh

        

VP - Operations

David Moriarty

        

VP - Regulatory Affairs

Marc Lesnick

        

Browse more venture capital transactions:

Prev: 2/21/2020: EnClear Therapies venture capital transaction
Next: 2/21/2020: Feather venture capital transaction

Share this article

Where The Data Comes From

We do our best to record tech company VC transactions. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary